PER 0.00% 8.1¢ percheron therapeutics limited

Ionis drug approval

  1. 300 Posts.
    lightbulb Created with Sketch. 833
    Ionis gains approval on Tofersen in Europe overnight. Very good news as this is also a second-generation antisense oligonucleotide (as ATL1102). This one is also for a rare disease ALS

    Tofersen is all about mediating mRNA degradation to prevent SOD1 protein synthesis and reduce levels of SOD1 protein.

    A nice precedent for ATL1102.


    https://www.prnewswire.com/news-releases/ionis-announces-european-medicines-agency-accepts-marketing-authorization-application-of-tofersen-to-treat-rare-genetic-form-of-als-301694129.html
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.